Increased Overall Survival in Patients With Stages I and II Diffuse Large B-Cell Lymphoma Treated With Radiation Therapy: A Surveillance, Epidemiology, and End Results (SEER) Analysis

A Ballonoff,R Mccammon,A Schwer,K Rusthoven,R Rabinovitch

doi:10.1016/j.ijrobp.2007.07.029

Increased Overall Survival in Patients With Stages I and II Diffuse Large B-Cell Lymphoma Treated With Radiation Therapy: A Surveillance, Epidemiology, and End Results (SEER) Analysis

A Ballonoff, R Mccammon + Show 3 more

Open Access

https://doi.org/10.1016/j.ijrobp.2007.07.029

Copy DOI

Journal: International Journal of Radiation Oncology, Biology, Physics	Publication Date: Sep 27, 2007
Citations: 1

Affiliation: University of Colorado Anschutz Medical Campus, University of Colorado Denver

#Surveillance, Epidemiology, And End Results #Diffuse Large B-cell non-Hodgkin Lymphoma + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

The role of radiation therapy (RT) in stage I and II diffuse large B-cell non-Hodgkin lymphoma (DLBCL) remains controversial. This analysis utilized the Surveillance, Epidemiology and End Results (SEER) database to assess the impact of RT on overall survival (OS) for early-stage DLBCL.

Full Text